Form D · Other Technology
Stride Therapy, Inc.
Brooklyn, NY · CIK 0001920819
Offering snapshot reported Jun 12, 2024 · SEC filing
- Reported sold
- $3.5M Offering amount: $5M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 28, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 12, 2024 | Initial | $3,500,000 | No comparison | 18 | SEC filing |
| Apr 1, 2022 | Initial | $2,500,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-515734
The Total Offering Amount and Total Amount Sold includes the conversion of $2,000,000 in outstanding convertible securities.
Source: Form D, filed Jun 12, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Blank | Director, Executive, Promoter |
| Omri Bloch | Director |
| Ryan Limor | Director, Executive, Promoter |
Issuer details
Industry: Other Technology (See others in industry)
Address:
41 Flatbush Ave, Ste 225
Brooklyn, NY, 11217
Brooklyn, NY, 11217